Publikationen der ALS-Forschungsgruppe an der Charité
Elective termination of respiratory therapy in amyotrophic lateral sclerosis
Meyer T, Dullinger JS, Münch C, Keil JP, Hempel E, Rosseau S,
Thalidomide causes sinus bradycardia in ALS
Meyer T, Maier A, Borisow N, Dullinger JS, Splettstösser G, Ohlraun S,
Progressive muscle atrophy. A rarely diagnosed variant of amyotrophic lateral sclerosis
Meyer T, Münch C, van Landeghem FK, Borisow N, Dullinger J, Linke
Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD
Münch C, Rosenbohm A, Sperfeld AD, Uttner I, Reske S, Krause BJ,
Frequency of a tau genotype in amyotrophic lateral sclerosis
Münch C, Prechter F, Xu R, Linke P, Prudlo J, Kuzma M,
Early-onset ALS with long-term survival associated with spastin gene mutation
Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH,
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis
Eschbach J, Schwalenstöcker B, Soyal SM,
Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis
Roth NM, Saidha S, Zimmermann H,
The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian syndromes
Stockmann M, Meyer-Ohlendorf M, Achberger K,
NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis
Blauw HM, van Rheenen W, Koppers
Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients
Lee T, Li YR, Ingre C,
A large genome scan for rare CNVs in amyotrophic lateral sclerosis
Blauw HM, Al-Chalabi A, Andersen PM,
Novel missense and truncating mutations in FUS/TLS in familial ALS
Waibel S, Neumann M, Rabe M,
No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohort
Fernández-Santiago R, Sharma M, Berg D,
